We found an increase in the expression of phosphorylated SAPK/JNK as well as phosphorylated c-jun indicating hyper activation of this pathway during CML progression (Figure 5G and corresponding densitometric analysis in Supplementary Information S3R). This evidence concerns the gene JUN and chronic myelogenous leukemia, BCR-ABL1 positive.